Fatal vaccine-induced immune thrombotic thrombocytopenia (VITT) post Ad26.COV2.S: first documented case outside US.

Autor: Rodriguez EVC; Department of Emergency Medicine, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Bouazza FZ; Department of Emergency Medicine, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Dauby N; Department of Infectious Diseases, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Mullier F; Namur Thrombosis and Hemostasis Center (NTHC), CHU UCL Namur, Université catholique de Louvain (UCL), Yvoir, Belgium., d'Otreppe S; Department of Laboratory Medicine, LHUB-ULB, Université libre de Bruxelles (ULB), Brussels, Belgium., Jissendi Tchofo P; Department of Radiology, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Bartiaux M; Department of Emergency Medicine, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Sirjacques C; Department of Intensive Care Medicine, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Roman A; Department of Intensive Care Medicine, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Brussels, Belgium., Hermans C; Division of Hematology, Hemostasis and Thrombosis Unit, Saint-Luc University Hospital, Université catholique de Louvain (UCL), Brussels, Belgium., Cliquennois M; Department of Clinical Hematology, CHU Saint-Pierre, Université libre de Bruxelles (ULB), Rue Haute 322, 1000, Brussels, Belgium. manuel.cliquennois@gmail.com.

Publikováno v: Infection [Infection] 2022 Apr; Vol. 50 (2), pp. 531-536. Date of Electronic Publication: 2021 Oct 09.